Zobrazeno 1 - 10
of 406
pro vyhledávání: '"Sabourin CL"'
Autor:
Henning L; Battelle Biomedical Research Center, Columbus, OH, USA., Anderson M; Battelle Biomedical Research Center, Columbus, OH, USA., Triplett C; Battelle Biomedical Research Center, Columbus, OH, USA., Smith T; Battelle Biomedical Research Center, Columbus, OH, USA., Boyce K; Battelle Biomedical Research Center, Columbus, OH, USA., Hendey L; Battelle Biomedical Research Center, Columbus, OH, USA., Ridenour A; Battelle Biomedical Research Center, Columbus, OH, USA., Eng J; Battelle Biomedical Research Center, Columbus, OH, USA., Schaeufele D; Battelle Biomedical Research Center, Columbus, OH, USA., Wilson E; Battelle Biomedical Research Center, Columbus, OH, USA., Sabourin CL; Tunnell Government Services, Inc, Supporting BARDA, Washington, DC, USA., Adams LE; Oak Ridge Institute for Science and Education (ORISE) fellow at BARDA, Washington, DC, USA., Babas T; Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA., Parish L; Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA., Wolfe D; Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Washington, DC, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 15; Vol. 19 (3), pp. 2290345. Date of Electronic Publication: 2023 Dec 19.
Autor:
Comer JE; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA., Brasel T; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA., Massey S; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA., Beasley DW; Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA.; Institutional Office of Regulated Nonclinical Studies, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA., Cirimotich CM; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA., Sanford DC; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA., Chou YL; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA., Niemuth NA; Battelle Biomedical Research Center, West Jefferson, OH 43162, USA., Novak J; AmplifyBio, West Jefferson, OH 43162, USA., Sabourin CL; Tunnell Government Services, Inc., Supporting Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA., Merchlinsky M; CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA., Long JP; Tunnell Government Services, Inc., Supporting Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA., Stavale EJ; CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA., Wolfe DN; CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA.
Publikováno v:
Viruses [Viruses] 2022 Oct 18; Vol. 14 (10). Date of Electronic Publication: 2022 Oct 18.
Autor:
Niemuth NA; Battelle, Columbus, OH 43201, USA., Sabourin CL; Battelle, Columbus, OH 43201, USA., Ward LA; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2022 Jul 29; Vol. 10 (8). Date of Electronic Publication: 2022 Jul 29.
Autor:
Carbonnelle C; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France.; Evotec Id, 69007 Lyon, France., Moroso M; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France., Pannetier D; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France., Godard S; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France., Mély S; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France., Thomas D; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France., Duthey A; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France., Jourjon O; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France., Lacroix O; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France., Labrosse B; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France., Raoul H; Inserm, Laboratoire P4 Jean Mérieux, 69007 Lyon, France., Osman KL; UK Health Security Agency, Porton Down, Salisbury, Wiltshire SP4 0JG, UK., Salguero FJ; UK Health Security Agency, Porton Down, Salisbury, Wiltshire SP4 0JG, UK., Hall Y; UK Health Security Agency, Porton Down, Salisbury, Wiltshire SP4 0JG, UK., Sabourin CL; U.S. Department of Health and Human Services (DHHS), Tunnell Government Services, Inc., Supporting Biomedical Advanced Research & Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), Washington, DC 20201, USA., Merchlinsky MJ; U.S. Department of Health and Human Services (DHHS), CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), Washington, DC 20201, USA., Long JP; U.S. Department of Health and Human Services (DHHS), Tunnell Government Services, Inc., Supporting Biomedical Advanced Research & Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), Washington, DC 20201, USA., Parish LA; U.S. Department of Health and Human Services (DHHS), CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), Washington, DC 20201, USA., Wolfe DN; U.S. Department of Health and Human Services (DHHS), CBRN Vaccines, Biomedical Advanced Research & Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), Washington, DC 20201, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2022 Jun 16; Vol. 10 (6). Date of Electronic Publication: 2022 Jun 16.
Autor:
Wolfe DN; U.S. Department of Health and Human Services (DHHS), Assistant Secretary for Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA), Washington, DC 20201, USA., Sabourin CL; Tunnell Government Services, Inc., Supporting Biomedical Advanced Research & Development Authority (BARDA), Assistant Secretary for Preparedness and Response (ASPR), U.S. Department of Health and Human Services (DHHS), Washington, DC 20201, USA., Merchlinsky MJ; U.S. Department of Health and Human Services (DHHS), Assistant Secretary for Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA), Washington, DC 20201, USA., Florence WC; U.S. Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Rockville, MD 20852, USA., Wolfraim LA; U.S. Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Rockville, MD 20852, USA., Taylor KL; U.S. Department of Health and Human Services (DHHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Rockville, MD 20852, USA., Ward LA; U.S. Department of Defense (DOD), Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), Fort Detrick, MD 21702, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2021 Sep 19; Vol. 9 (9). Date of Electronic Publication: 2021 Sep 19.
Autor:
Li, Ping1 (AUTHOR), Kuang, Jilin1 (AUTHOR) JilinKuang0721@163.com
Publikováno v:
Journal of Ovarian Research. 9/17/2024, Vol. 17 Issue 1, p1-13. 13p.
Autor:
Niemuth NA; Battelle Biomedical Research Center, West Jefferson, Ohio, United States of America., Rudge TL Jr; Battelle Biomedical Research Center, West Jefferson, Ohio, United States of America., Sankovich KA; Battelle Biomedical Research Center, West Jefferson, Ohio, United States of America., Anderson MS; Battelle Biomedical Research Center, West Jefferson, Ohio, United States of America., Skomrock ND; Battelle Biomedical Research Center, West Jefferson, Ohio, United States of America., Badorrek CS; Contract Support for the U.S. Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), Fort Detrick, Maryland, United States of America., Sabourin CL; Battelle Biomedical Research Center, West Jefferson, Ohio, United States of America.
Publikováno v:
PloS one [PLoS One] 2020 Oct 29; Vol. 15 (10), pp. e0241016. Date of Electronic Publication: 2020 Oct 29 (Print Publication: 2020).
Autor:
Anderson MS; Battelle, West Jefferson, Ohio, United States of America., Niemuth NA; Battelle, West Jefferson, Ohio, United States of America., Sabourin CL; Battelle, West Jefferson, Ohio, United States of America., Badorrek CS; U.S. Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), Joint Program Manager for Chemical Biological Radiological and Nuclear Medical (JPM-CBRN Medical), Fort Detrick, Maryland, United States of America., Bounds CE; U.S. Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), Joint Program Manager for Chemical Biological Radiological and Nuclear Medical (JPM-CBRN Medical), Fort Detrick, Maryland, United States of America., Rudge TL Jr; Battelle, West Jefferson, Ohio, United States of America.
Publikováno v:
PloS one [PLoS One] 2020 Aug 25; Vol. 15 (8), pp. e0238196. Date of Electronic Publication: 2020 Aug 25 (Print Publication: 2020).
Autor:
McGarry KG; Battelle Memorial Institute, Columbus, OH 43201, Ohio., Schill KE; Battelle Memorial Institute, Columbus, OH 43201, Ohio., Winters TP; Battelle Memorial Institute, Columbus, OH 43201, Ohio., Lemmon EE; Battelle Memorial Institute, Columbus, OH 43201, Ohio., Sabourin CL; Battelle Memorial Institute, Columbus, OH 43201, Ohio., Harvilchuck JA; Battelle Memorial Institute, Columbus, OH 43201, Ohio., Moyer RA; Battelle Memorial Institute, Columbus, OH 43201, Ohio.
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2020 Mar 01; Vol. 174 (1), pp. 124-132.
Autor:
Sabourin, Cl�ment
Publikováno v:
Nouveau Projet; automne/hiver2019, p70-73, 4p, 2 Color Photographs